Today, competing successfully in the Life Sciences market demands the right combination of business agility and control. Agility so that organizations can get their product to-market quicker and control to ensure compliance across local market requirements.
But this industry, which is subject to stringent, diverse and frequently changing regulation, has a tendency to manage content for international markets in an inefficient and error-prone way.
Even with the continued advances in electronic content management, many companies in the Life Sciences industry tend to manage local translations in a highly fragmented way – despite escalating costs and the risk to safety and speed-to-market.
Amplexor’s Jason Arnsparger will share a use case and prescribe a more systematic approach.